The scientific proof of the efficiency of Haarlem oil

 

• Kiener
• R. Du Boistesselin
• B. Leroux
• L. Bory

From alchemy to the high resolution of mass spectrograph from the Doctor Kiener

 

The sacred plant of Gabon, « Ilboga » becomes the first in worldwide scientific news, following work by an American group.

This plant has been known since the last century, existing in France as a special pharmaceutical method in the thirties, however, disappeared, like many other ancient specialties (The Americans preciously conserve in their therapeutic arsenals, these old specialties under the name of “Grandfathers product”).

Many of the new pharmaceutical molecules are originated from traditional knowledge and owe their new popularity to the simple fact that a scientific group have had access to this ancient knowledge and that the methods of modern pharmacology permits the isolation of certain active principals. A sort of transfer is actually assisted from a primitive society to a scientific society and the molecule that is recaptured, acquires a famous notoriety. It is simply forgotten that this process is implicitly validated, not only for the substance but also for the steps that are driven to its choice, in which we should question and encourage by entering into the logic, although it was an ancient choice of plants or reserved substances.

For many years, I have prescribed an old French specialty, which has been on the market since 1924: Haarlem Oil, a combination of Sulphur, Pine Turpentine and Linseed Oil, which now exists in capsules and facilitates usage.

Few doctors only know of its existence and its history is actually significant for the many remedies in which the roots are attached to traditional knowledge, the logic very different from that of today. This traditional alchemy proved to be effective, as modern critics examined the remedy. Remedies, like “Ilboga” risks to disappear before it is even noticed, as there will not always be a scientific group to popularize it. Haarlem Oil has not always been around but this remedy has been used since the 17th century. It resulted from the work of the alchemist Tilly, who continued the work of Paracelse and his assistant Van Helmont, who searched to resolve the alchemical arcanum. Due to the determining action of the great Doctor Hermann Boerhave, from the University of Leyden, who used this remedy especially for urinary lithiasis and biliary.

Haarlem Oil, established since 1696, was very popular all over Europe. Those who represented Haarlem Oil in the alchemist logic were not part of the present. However what we need to know is that the objective of this was medical and consisted of “opening” the salts, the metals and metalloids so that could be therapeutically active. (Today we use the term “bio-available”, as this term is a reducing agent in relation to alchemic procedures.

Paracelse, Van Helmont and their successors, Tilly and Boerhave, were convinced themselves that the illness was a result of “tartaric of the organism” and it was necessary to find a solution to “melt the tartar”. (Today we use the term “eliminating of circulating toxins or deposits”). We are not surprised to learn that Haarlem Oil was used for this solution: it was the great remedy of “Gravelle” (Today it is commonly known as urinary lithiasis and biliary). In 1963 Haarlem Oil appeared with these properties in the medical encyclopedia of Professor Jean Hamburger. It was also cited in medical journals in the hospitals of Paris (No. 9 – 1963) as an inescapable remedy of lithiases.

What is more surprising is when we know what represents the “sulphur” of the alchemists – it is the confirmation. The alchemists considered that sulphur is the best carrier of energy and that the central role of sulphur is considered in energetic metabolism in a human, especially in the function of the mitochondrion. (Krebs cycle and respiratory chain).

Haarlem Oil is today partly deciphered (fully in the chemical point of view) and its action could be partly explained by the presence of a non-oxidised sulphur, colloidal metalloids, in which the bio-availability is astounding: it is found in the lungs after half and hour and in the intervertebral joints after an hour. (“open sulphur” by the alchemists). The role of sulphur is that important but we end up forgetting it. Consisting of sulphuric amino acids (methionine, cysteine, taurine), sulphur has a structural role in proteins, in the tissues, the bones, the skin and a plastic role in the cartilages and the arterial walls. Clycosaminoglgycanes, like chondroitine sulphate acid, heparin sulphate or dermatome sulphate, has a functional role in the energetic metabolism as a sulphur mineral or as constituting the different enzymes in the respiratory chain or the Krebs cycle (Fad-Nad Coenzyme A-ferredoxine). A protective role in the mechanism against the free radicals (glutathione) but also on the level of the lungs in the regulation of the mucus system by a fluidity action, by a rupture of the disulphured bridge and indrected by its corticolike action, as Haarlem Oil reacts as a natural corticostimulant of the suprarenals.

An anti-inflamatory action is evident, as well as an antiseptic action. All these actions equally explain the anti-rheumatic actions of the remedy as it is known that an inflammation is a great producer of free radicals, therefore a huge consumer of glutathion. The salicylic acid, also indometacine are responsible for the urinary leakage of sulphur, therefore it is necessary for a sulphur complement at the time of anti-inflammation.

It has to be remembered that the role of sulphur as an eliminator of toxins from the hepatic level, either by sulphuric-conjugation or either by taurine and the biliary elimination. The sulphur in food contribution is essentially constituted in the sulphuric amino acids, especially in methionine. Certain plants contain sulphur : horseradish, cabbage, onions and garlic.

Besides bronchitis and rheumatism, Haarlem Oil also has success with those that have toxins to eliminate: sportsmen in their recuperation phase and those that want to stop smoking.

It is therefore understood that the therapeutic action of this remarkable remedy, used by adults as a treatment of attack in
3 x 2 capsules per day, before meals, during eight days, followed by 3 x 1 capsules during fifteen days. For babies and children, the dose is halved.

"The last but not least" of this remedy costs around a dollar a day of treatment.

In conclusion, I simply say: when an ill person suffers, firstly assure yourself that he is not lacking in sulphur. It is not just a simple play on words - I see illnesses everyday in my consulting room. Try, like myself, starting by asking the Lefevre laboratory to send you an actual up-to-date scientific document and go to your nearest library get a book on alchemy.

Go to top

Publication R. du BOISTESSELIN of 1959

 

[New research on the stimulation of the pituitary-adrenal axis by the oral administration of a sulfurated terpene.]

Reference: 
 

• Therapy 1959, 14:1044-52 

In a previous study (Thérapie. 1958, 13 (3) :527-37), the authors demonstrated histologically on guinea pigs and bioclinical on inpatients, the significant functional stimulation that sulfo-terpene carries on cortico-adrenal stimulation characterized: 
 

• In guinea pigs, for obvious hyperplasia of the fasciculata, a very substantial increase of the lipid load. 
• In humans, for a steady and often very important for the elimination of cortico-steroids in urine. 

In this new study, which aimed to clarify the mode of action, the authors carried out: 
 

1. Histological comparison of adrenal, pituitary and other endocrine glands taken from guinea pigs treated and control guinea pigs. 
2. Tests Sayers and Simpson performed on Wistar rats.

Here are their conclusions: 
 

• The sulfur-containing terpene (+) acting, not by acting cortico-primary, but by stimulating the secretion of cortico-Trophine pituitary (ACTH). 
• The sulfur-containing terpene seems exert any action on the thyroid, gonads, pancreas, adrenal medulla, and tolerance seems excellent. 
• (+) Therbinthiol.

You can read the following links for more information: 
 

• http://www.ncbi.nlm.nih.gov/pubmed: reference to publication in the MEDLINE database 
• http://www.journal-therapie.org: website of the publisher

Go to top

Clinical report from Doctor B. Leroux in the traitement cases of chronic bronchitis

 

Justification of the therapeutic trial :

The cases of chronic bronchitis was frequently observed in paediatrics.

The significance of mucus modifiers in the treatment is actual, as witnessed in numerous publications and congresses that have treated it, among those that cited the latest symposiums: mucus and respiratory illnesses Paris, October 1988 and Bordeaux, May 1989.

The relevant cases of chronic bronchitis have come about due to various causes :

• Recurring infections in the E.N.T. sphere
• Trouble in swallowing found a frequent breathing pathology.
• Bronchial Dsypnoea
• Abnormality of the vibratile cilia

It has to be added:

• The local bronchial tracheal lesions (eg. stenose tracheal post-intubation)
• The secondary bronchopneumonia dysplasies at long-assisted ventilation
• Mucoviscidosis
• Viral bronchioles in new-borns, etc...

Most of these etiologies are worsened by the eventual existence of an allergic ground or by a bronchial hypersensitivity originating from exogenous (passive tobacco, for example).

Page 1

Clinical tables carried out at the time during chronic bronchitis, are dominated by:

The inflammation of chronic bronchial tracheal.

• With the huge mucus secretion, a cumbersome factor and persistent cough.

The inflammation favorites the appearance of frequent episodes of viral or bacterial infection, modifying the characters of bronchial secretion that become purulent.

The aetiological diagnosis reached by chronic bronchitis and the evaluation of the respiratory function requires sometimes complimentary extensive examinations (bacterial and viral radiology, immunology, endoscopic examinations, functional lung tests, etc....)

Page 2

The treatments

The treatments of chronic bronchitis syndromes consists of avoiding an aggravated evolution and is sometimes torpid from pathological bronchopneumonia against the definite internal injuries, particularly in the dilatation type of the bronchial tubes, in which the seriousness is known for the prognosis pulmonary function and vital in long terms.

The treatments call for aid
 

• From drainage physiotherapy
• From antibiotic cures at the time of secondary infection
• At modifications of the secretion of bronchial mucus
• At sulphuric therapeutic administered under different forms, which includes, thermal cures

If the interest of these treatments is undeniable, the disadvantages could be underlined

• Allergic risks connected to antibiotics
• Cost of treatments (physiotherapy, antibiotics, thermal cures, immunotherapy)
• Relative inefficiency of therapeutic sulphur in the normal prescribed form.

Page 3

Clinical documentation

In the choice of treatment in the curative and prevention of chronic bronchitis, the interest is to benefit, sometimes though therapeutic ways
 

• Effective
• Non-poisonous
• Practical way of administrating
• The daily cost is not expensive

All the elements that drives us to use and appreciate the antiseptic clinical effectiveness and mucus modification of Haarlem Oil in children that suffer from various aetiological chronic bronchitis.

Page 4

Haarlem Oil

Used in France since 1924.

Monograph from Vidal, viewed by the Alexandre commission (star monograph 1981)

The matter of sulphured terpens, in which the properties are that of the components, oxides of organic sulphur, terpene essence from turpentine.

Strong antiseptic action linked to the properties of turpentine essence.

Modified actions clarified from the numerous secretions, especially bronchial linked with sulphur (also see Haarlem oil as a Urinary tract infection home remedies).

The diffusion of Haarlem Oil is large in the organism, as it is experimentally shown by pharmacological studies. Its benefits are aimed at the digestive absorption, biliary elimination, tissue distribution, the constant plasma and the excretion of S35 in rats, after a unique oral dose of Haarlem Oil (therapeutic dose of 10mg/kg).

The study of Professor Jacquot (1984) shows an important tissue distribution and precociously, 15 minutes and on hour at the level of the bronchial-pulmonary tissues. The anti-inflammatory action is experimental, reported in a study by Professor Jacquot (1986), which notes a significant elevated action of SOD, probably by elevation of the thiols in the plasma. The absence of toxicity in Haarlem Oil relieves the three orders of established facts.

No case of intoxication has been reported by this medicine, since it has been on the market since 1924.

The study of toxicology, determines the lethal dose of 50 (EVIC CEBA 1988) from 2500mg/kg, is consequently infinitely higher than the recommended therapeutic dose, by the laboratory: 10mg/kg.

The risk of accidental intoxication is made non-existant and mainly in children.

One method of packaging is in a bottle of 10ml.

In the form of capsules, in a box of 32 capsules, 6.4g.

Due to the strong taste of the product, this specialty in the droplet form is highly sweetened for its administration. Children, on the other hand, chew a tablet and spit it out immediately.

Page 5

Methodology of clinical studies

Posology :

Haarlem Oil is prescribed :

• At a dose of 10mg per kilo and an initial cure of 10 days
• Eventually to be repeated 8 to 10 days per month, if required

Mode of administration :

Under the form of of drops mixed with sweet food.

Choice of patients :

25 children underwent a treatment of Haarlem Oil, after information provided and consent of the parents.

Age of the children :

Between 5 months and 8 years.

All the patients had clinical symptoms of various etiological chronic bronchitis reported in the individual files and synthesized in the attached table.

Haarlem Oil was prescribed, excluding any other mucus-modifying treatments.

Remarks :

It is noted that in only 2 patients, the assessments permitted relief from a very positive allergic ground.

Page 6

Clinical file N°2

1. Name : Aude B.
2. Date of Birth : 20.09.1984
3. Gestational Age : 38 weeks
4. Weight at Birth : 3 350 g
5. Neonatal Pathology : None

Evolution

From the age of 12 months: Rhinopharyngeal infections and repeated otitis, treated by repeated antibiotics and local disinfectants.

• Evolution towards a chronic bronchitis syndrome with subsequent infectious episodes
• At two and a half years old, adenoidectoderm without effect
• The allergic assessment is negative; test of sweat negative
• February 1988: Age: three years and six months. The child was tired by the multiple episodes of infectious bronchitis with permanent hypersecretion. The lung x-ray confirmed the syndrome of diffused bronchitis. Start of the treatment of Haarlem Oil 10 mg/kg, 10 days per month. The effect is remarkable with the disappearance of bronchial hypersecretion and cough, in less than one week. The effect was observed, since the first cure, and maintained by one consolidated cure, using the same posology, one month later.
• March 1990 : Age: five years and six months. Normal growth. The sensitivity of the child to frequent infectious bronchial hypersecretion, especially in the period of Autumn-Winter, has made to resume the treatment of Haarlem Oil, always at the same posology of 10 mg/kg with an excellent effect, avoiding a repetition of antibiotic cures.

Conclusion

The syndrome of secondary chronic bronchitis to E.N.T. recurring infections. Remarkable effect and residuals from Haarlem Oil.

Page 7

Clinical file N°3

1. Name : Pamela B.
2. Date of Birth : 03.08.1984.
3. Gestational Age : 33 weeks
4. Weight at Birth : 1940 g
5. Neonatal Pathology : Birth by cesarean for hemorrhagic placenta / Infection of the hyalin membranes

Assisted ventilation during eight days: Favorable evolution and out of care at J 34

Evolution

Persistence of a hoarse voice with laryngeal dyspnea.

E.N.T. Infections (rhinopharyngitis and otitis) at consequent repetitions of permanent bronchial congestion

• At 10 months, the laryngoscopy confirmed the existence of a tracheal stenosis under-glotal, consequences of intubation.
• Adenoidectoderm

Following treatment : Pulmonary physiotherapy

Immunotherapy

Disinfectants and local fluids

• Between one and two and a half years old, persistence of multiple bronchial infection, requiring one occasion of hospitalization for lung infected bacteria (HAEMOPHILUS).
• At two years and nine months: New bronchoscopy : persistence of tracheal roll and the existence of numerous intra-bronchial mucomucus-purulent secretions.
• At three years and eight months : Clear voice, good growth. Nevertheless, a persistent E.N.T. infection (mucus otitis and a reappearance of adenoide hypertrophy) still accompanied by a major bronchial congestion. The lung x-ray confirmed that the bronchitis had diffused with peripheral emphysema.
• At three years and ten months (April 1988) : Initial treatment of Haarlem Oil, 10mg/kg, 10 days per month. The effects were immediately efficient with a disappearance of the cough and the bronchial congestion, within four to five days. The monthly treatments were at that time followed at 10 days per month and were pursued thereafter, during six months. A systematic way as treatments were discontinued and repeated only at the reappearance of a bronchial infection, which were less frequent.
• At five years and nine months (May 1990) : Normal growth, normal lung functioning, normal lung x-ray, no infection nor bronchial-pulmonary pathology since one year.

Conclusion

Recurring secondary bronchial infections, bronchial-pulmonary at tracheal stenose, consequence of intubation. Remarkable effect of Haarlem Oil.

Page 8

Clinical file N°4

1. Name : Alexandre M.
2. Date of Birth : 30.12.1984.
3. Gestational Age : 41 weeks
4. Weight at Birth : 3 380 g
5. Neonatal Pathology : None

Evolution

Bronchial virus at two months, otitis purulent at five months. Recurring otitis (transtympanic drainage at 10 months), with rhinopharyngitis and bronchial congestion.

• Adenoidectoderm at ten months
• Between ten months and two and half years old, multiple otitis infections and bronchitis justifying the antibiotic treatments and the repeated symptoms with physiotherapy drainage. The allergic assessment is negative, test of sweat negative, lung x-ray diffused bronchial syndromes without thoracic distension.
• September 1987 (two years and nine months), weight-16 kg. Unsuccessful treatment of a new bronchial episode with antibiotics (CEPHOPEROS), followed by an initial treatment of Haarlem Oil, 10mg/kg, during ten days. The effectiveness was excellent with the disappearance of clinical signs and lung congestion within four days. Reinforcement treatment systematically practiced one month after the initial treatment, with the same posology.
• February 1988 (three years and two months) : Very good improvement. Had not any infection since the second cure of Haarlem Oil

The child has not been treated since this last consultation.

Conclusion

Chronic bronchitis a post-infection of E.N.T. Remarkable effect from Haarlem Oil since the first treatment for bronchitis.

Page 9

Clinical file N°5

1. Name : Thibaut B.
2. Date of Birth : 25.10.1985.
3. Gestational Age : 39 weeks
4. Weight at Birth : 3 250 g
5. Neonatal Pathology : None

Evolution

At the age of 16 months, multiple rhinopharyngeal infections with mucus otitis and bronchial syndromes, resulting in persistent cough and noted by lung x-ray, with also bronchial congestion and thoracic distension.

• At two years, the allergic assessment is negative, test of sweat negative
• Growth and weight have not changed
• January 1988 (two years and three months) : Treatment of a new bronchial infection, initial treatment of Haarlem Oil, 10mg/kg. Immediate effectiveness in less than one week, but recurrence of cough and bronchial-pulmonary congestion fifteen days after stopping the treatment. Decision is made to continue Haarlem Oil for a monthly cure of 10 days per month, at the same posology.
• May 1988 : After four monthly treatments of Haarlem Oil, total disappearance of the major lung signs, congestion and cough. Weight gain, over 1kg in four months.
• April 1990 : Four and a half years old. The child was regularly observed. Regular growth for age. Perfect maintenance of lung function, in which the unusual episodes and occasional infection, observed since two years, justified the simple and effective treatment of Haarlem Oil and always at the same posology.

Conclusion

Secondary chronic bronchitis to multiple E.N.T. infections. Remarkable effect from Haarlem Oil with a positive indirect effect on growth.

Page 10

Clinical file N°7

1. Name : Charles Henry B.
2. Date of Birth : 29.03.1985
3. Gestational Age : 40 weeks
4. Weight at Birth : 2 590 g
5. Neonatal Pathology : Delay in intra-uterine growth

Evolution

From the age of three months, multiple rhinopharyngeal infections and mucus otitis developing into deafness of 25 DB, brought into evidence at three years.

Cough and bronchial congestion almost permanent. Multiple antibiotic treatments.

Allergic assessment is negative, test of sweat negative

Modest growth.

• April 1988 (three years) : Treatment of a new E.N.T. infection and bronchitis by an initial treatment of Haarlem Oil, 10mg/kg per day, during 10 days. Excellent effectiveness with the disappearance of clinical signs within four to five days, without relapse. Second systematic treatment one month after the initial treatment, with the same posology.
• March 1990 (five years) : The child was occasionally observed. Regular growth for age. Disappearance of the pathological E.N.T. and initial bronchitis. The appearance of occasional infections has brought about the re-use of Haarlem Oil, with the same effect as the initial treatment, avoiding resorting to antibiotics.

Conclusion

Recurring E.N.T. infections with deafness from post-otitis and chronic tracheal bronchitis. Major effectiveness and support from Haarlem Oil, from the initial treatment, with the influence on the revival of normal growth.

Page 11

Commentaries

Our results, reported by clinical studies of 25 children, confirms the interest of the use of Haarlem Oil, in the treatments of chronic bronchial-pulmonary.

Recent publications (4,5) clearly show that the effectiveness of what was called "mucus-ciliary escalator" depends not only on the integrity of the epithelia cells, the co-ordination and movement of the ciliaries, but also the mucus rhinonogy characters, in which the threads and the viscoelasticity are altered and reduced in the cases of recurring bronchial-pulmonary infections.

Thus, the justification of the use of Haarlem Oil is as follows :

• The knowledge and its mucus modifying properties and pulmonary antiseptics known since a very long time.
• The absence of toxicity.
• Recent experiments done on animals have authorized and given human beings a bio-availability and an identical action, with an important tissue fixation of sulphur on the level of bronchial-pulmonary.
• Our studies have been based on simple observations of clinical signs and on evolution.

It is difficult, and also the opinion of J. Battin (1), to have a large scale of controlled tests appreciating placebo and the effectiveness of mucus modification, for the reason of diverse etiologies competing with chronic bronchial-pulmonary pathologies and the fact of complex complementary explorations. For these reasons, we have chosen the clinical appreciations and evolution, compared to other products, currently proposed in the treatment of these symptoms. In 68 % of the cases in our series, we observed since the first treatment of Haarlem Oil, the clarification and the disappearance of bronchial hyper-secretion, in less than one week. This confirms the positive rheological action of the antiseptic action of Haarlem Oil. These actions are continued with permanence after several weeks, in the majority of the cases. In 70 % of children, for which the renewing of the treatment of Haarlem Oil was proposed monthly, effectiveness followed favorably, bringing a total recovery of chronic bronchial-pulmonary, in less than four months. We can measure the savings also realized by the multiple treatments previously used (particularly the repeated antibiotic treatments). In the other cases, 60 % of which the monthly cures were continued either systematically or by request, the antiseptic action and clarification of trachael-bronchitis secretion were shown. Haarlem Oil obtained the disappearance of all congestion symptoms during the long periods and has also significantly reduced the episodes of secondary infection, uniquely observed in children, in which the attack of chronic bronchial-pulmonary was considered as definitive.

The deleterious action on the bronchial mucus of free radicals of oxygen, is actually well known. They are incriminated in the pathology of the bronchial-pulmonary dysphasia (6). They are directly incriminated in the destruction of the local cellular structures and indirectly in the flow of the local inflammatory cells : macrophagics and polynuclears. All these factors contribute to the serious transudation of bronchial-alveolar.

The liberation of leukotrienes by the macrophages (3) favourise, by their bronchial-constructural action, the retention in the air passage. The role of toxic metabolizes of oxygen arising from the respiratory after-effects is more important than the antioxidant system of new borns, who are immature.

Therefore, the study of C. Jacquot (2), appears that it is essential. It has demonstrated, in animals, the antioxidant activity of Haarlem Oil. The activity of the super-oxidised dismutase enzyme, principal antioxidant enzyme of the organism, is significantly higher in the cases treated by Haarlem Oil, than in the witness groups. This increase reported an elevation of thiol groups in the plasma.

Page 12

Conclusion

Used in 25 children that were infected with chronic bronchial-pneumonia of diverse etiologies, Haarlem Oil has shown a good effect in 68 % of the cases, since the first treatment and in 70 % of the cases, where the treatment was renewed monthly, the reduction and disappearance of clinical symptoms of bronchial hyper-secretion.

This action was clearly superior to the mucus-modifying medication, comparably prescribed habitually.

It is desirable that the studies are continued particularly at the pharmacological level, next to the antiseptic actions and classic mucus-modification known, of Haarlem Oil. Its antioxidant activity was recently brought into evidence, by the elevation of the activity of the super-oxidised dismutase, essential appearance in the prevention of pulmonary bronchial-dysplasia.

The study continues for more than 25 pages, that is held at your disposition, by simply inquiring at  This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Go to top

Sulphur Chemotherapy, Louis Bory, MEDICAL PROGRESS, March 26th 1938, no 13, page 454

 

General magazine, comprehensive on sulphur chemotherapy, which consists of or dominates all the others.

The author commences by a chapter of chemical physio-patbologic of sulphur where he clarifies the following conclusions, in which concern the general indication of sulphur chemotherapy

1. The first chemotherapy has to be diet; the diet has to assure a sufficient quantity of active assimilated sulphur.
2. Sulphur is utilized in all nutritional disorders, especially when there is an attack on the organs rich in sulphur (liver, skin, articulations).
3. Sulphur is a useful anti-infectious agent , as underlined today, the sulphorchryso therapy and the sulphonamide therapy.
4. It is an anti-toxin, like nucleus of sulpho-conjugation, an employer in the toxaemia and its intolerance.

M. Bory recalls later the :

Sulphur chemotherapy agents

Briefly, it consists of :

1. Minerale sulphur, and the author insists on the general properties of sulphur in nature or colloidal (anti-parasite, internal antiseptic, laxative, anti-toxic, anti-catarrhal, anti-rheumatism) on a large utilization of sulphur from mineral water, on the current use of hypo-sulphides and its sulphates.
2. Organic sulphur, most recently used and in which we actually tend to add a sulphuric group to chemotherapy products. The Sulphur brings a synergistic action or a general protector contribution to the product which is added. It is noted that parental body injections of a thiol group or disulfides, are pyretogenous and generally painful. Finally, the distinction between non-oxydised sulphur and oxydised sulphur are false,as far the anti-parasite actions and anti-infection actions are concerned, from the given product.

In this way, it has been particularly drawn to use :

1. Golden sulpharic salts for the treatment of tuberculosis and rheumatism.
2. The self-made products active in the streptococcus, which we actually use against the coccoid infections in general.
3. The sulphuric oils.
4. Thiofene, introduced in therapeutics by the author. The soluble carboxyl thiofene injectable through the subcutaneous and intravenous, is the simplest from, which is the most active and the most practical for sulphur used by the main tracts. It does not provoke any local or general incidents. The author has studied its action in serious infections, Bouillaud's illness, tuberculosis, the recommendation at the critical stage of general or lung infections, articulations by intravenous (0.10 in 2 cmc of water, one to two times a day). Thiofene in capsules for bones seemed to be reserved for the subacute or chronic cases (0.05 or more, 3 times a day) and when the intestinal dysfunction indicates appearance.
5. The living sulphur , fabricated by the organisms : such as the glutathione, insulin, the opiotherapeutical products, cysteine, sulphuric water.

Applications of sulphur chemotherapy

The indications of sulphur chemotherapy can be classified under three big groups

1) Sulphur chemotherapy for nutritional problems

General Nutrition :

Conditions increase the need for sulphur for the organism : feverish illnesses, nitrogenous diets, growth, etc. Next is the sulphuric medication, preferably under the form of thiopene and the hypo-sulphates, that is used in athrepsies, consumptions, iron convalescence. In diabetes sulphur appears to have a real utility in the colloidal form, or under the form particularly brought by hydrologic treatment. New studies are yet to be done in this domain.

Local Nutrition :

Pulmonary - The sulphuric mineral waters are particularly used for chronic rhino-bronchitis.

Cutaneous - Sulphur is indicated in the intolerant reactions or in sensitivity, in the seborrhoic states or acne, in the para-keratosis, certain vesiculaire-bubble infections.

Articulation - Sulphur is a capital element of articulatory balance and sulphur chemotherapy is effective in most part of the osteoarthritis. It regulates the metabolism of sulphur by the presence of other metabolisms.

2) Anti-toxic sulphur chemotherapy

The anti-toxic action of the liver depends on its reserve in glutathion. The anti-toxic supply of sulphur is used in the sharp saturnine intoxication, mercury treatment, bismuth medication, treatments by arseno-benzenes, the intolerance states or sensitivity treated by soda hypo-sulphates or magnesium.

3) Anti-infectious sulphur chemotherapy

Sulphur is used as an anti-parasite in external applications, as an intestinal antiseptic and as an anti-helminitic. The anti-microbe action is well known and has been largely confirmed by the general use of sulpharic products, in which we know the favorable action in the coccus.

In conclusion, the author has underlined the sensitivity of another virus, only coccus, from sulphuric medication.

Invisible Neutrophic virus of shingles and herpes

Unknown virus of the Bouillaud illness

Treponema from syphilis (in the sense that the sulphur has provided a point in the treatment of syphilis)

It seems that the question of therapeutic sulphur of tuberculosis under the hydro-mineral form or chemotherapy has to be retaken and that for a cure, the anti-tuberculosis chemotherapy has to contain sulphur.